Literature DB >> 3134291

A comparison of the cytolytic properties of murine primary CD8+ cytotoxic T lymphocytes and cloned cytotoxic T cell lines.

C Nagler-Anderson1, N L Allbritton, C R Verret, H N Eisen.   

Abstract

Lysates of many highly cytolytic murine primary CD8+ cytotoxic T lymphocytes (CTLs) have no detectable hemolytic activity and only traces of serine esterase activity, indicating a striking paucity or absence of the perforin-rich secretory granules that are abundant in the cytoplasm of murine cloned CTL cell lines. Nevertheless, the primary CTLs are almost as resistant to granule-mediated lysis as CTL cell lines. Moreover, target cells that are lysed by all CTLs so far tested, whether primary or cell lines, show similar rapid and marked increases in intracellular calcium and breakdown of DNA into nucleosome-sized fragments. A parsimonious explanation for all of these findings is that primary CTLs, like the CTL cell lines, exercise their cytolytic activity by means of perforin, but the amounts needed are extremely small and below the level of detection by the current relatively insensitive hemolytic assays.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3134291     DOI: 10.1111/j.1600-065x.1988.tb00753.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  3 in total

1.  Inhibition of T-cell mediated cytotoxicity by Novobiocin suggests multiple pathways for both CD4+ and CD8+ cytotoxic T cells.

Authors:  P J Wood; A G Stansfield
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

2.  The lysis of cytotoxic T lymphocytes and their blasts by cytotoxic T lymphocytes.

Authors:  B Schick; G Berke
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

3.  Interleukin 2 induction of pore-forming protein gene expression in human peripheral blood CD8+ T cells.

Authors:  M J Smyth; J R Ortaldo; Y Shinkai; H Yagita; M Nakata; K Okumura; H A Young
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.